Skip to main content
SpringerLink
Log in

Valvular Heart Disease

  • Living reference work entry
  • First Online:
Family Medicine

  • 1465 Accesses

Abstract

The challenge of valvular disease is in distinguishing the benign nonprogressive disorder from a concerning and potentially dangerous structural disease [1, 2]. The family physician is in a particularly challenging position because we will be addressing these potential concerns at every stage of life and often may be dealing with determining the significance of a new heart sound as an incidental finding. Valvular disease may lead to decreased functional status, permanent structural changes, and increased mortality [3, 4]. Timely diagnosis and appropriate testing and consultation are the goals of the family physician, in order to prevent the negative sequelae of inappropriately addressing valvular disease. Learning maneuvers and understanding the sounds present within the heart facilitate appropriate diagnosis [5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014;30(9):962–70.

    Article  PubMed  Google Scholar 

  2. Giese EA, O’Connor FG, Brennan FH, Depenbrock PJ, Oriscello RG. The athletic preparticipation evaluation: cardiovascular assessment. Am Fam Physician. 2007;75(7):1008–14.

    PubMed  Google Scholar 

  3. Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010;85(5):483–500.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440–92.

    Article  PubMed  Google Scholar 

  5. Ashley EA, Niebauer J. Cardiology explained. London: Remedica; 2004.

    Google Scholar 

  6. O’Brien KD. Epidemiology and genetics of calcific aortic valve disease. J Investig Med. 2007;55(6):284–91.

    Article  PubMed  Google Scholar 

  7. Boudoulas KD, Borer JS, Boudoulas H. Etiology of valvular heart disease in the 21st century. Cardiology. 2013;126(3):139–52.

    Article  PubMed  Google Scholar 

  8. Galli E, Lancellotti P, Sengupta PP, Donal E. LV mechanics in mitral and aortic valve diseases: value of functional assessment beyond ejection fraction. JACC Cardiovasc Imaging. 2014;7(11):1151–66.

    Article  PubMed  Google Scholar 

  9. Tashiro T, Pislaru SV, Blustin JM, Nkomo VT, Abel MD, Scott CG, et al. Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice. Eur Heart J. 2014;35(35):2372–81.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation. 2014;129(21):2158–70.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Grayburn PA, Carabello B, Hung J, Gillam LD, Liang D, Mack MJ, et al. Defining “Severe” secondary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol. 2014;64(25):2792–801.

    Article  PubMed  Google Scholar 

  12. Pibarot P. Valvular disease in 2010: evolution and revolution in risk stratification and therapy. Nat Rev Cardiol. 2011;8(2):75–7.

    Article  PubMed  Google Scholar 

  13. Chandrashekhar Y, Westaby S, Narula J. Mitral stenosis. Lancet. 2009;374(9697):1271–83.

    Article  CAS  PubMed  Google Scholar 

  14. The Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation. 2007;116:1736–54.

    Article  Google Scholar 

  15. Duval X, Hoen B. Prophylaxis for infective endocarditis: let’s end the debate. Lancet. 2014 (London).

    Google Scholar 

  16. Houston BA, Stevens GR. Hypertrophic cardiomyopathy: a review.

    Google Scholar 

  17. Kardasevic M, Kardasevic A. The importance of heart murmur in the neonatal period and justification of echocardiographic review. Med Arch. 2014;68(4):282–4.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Windram JD, Colman JM, Wald RM, Udell JA, Siu SC, Silversides CK. Valvular heart disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2014;28(4):507–18.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family and Community Medicine, University of Minnesota North Memorial Family Medicine Residency Program, 1020 West Broadway Ave., Minneapolis, MN, 55411, USA

    Reneé Crichlow

Authors
  1. Reneé Crichlow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reneé Crichlow .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of Nebraska, Omaha, Nebraska, USA

    Paul Paulman

  2. Virginia Beach, Virginia, USA

    Robert Taylor

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this entry

Cite this entry

Crichlow, R. (2015). Valvular Heart Disease. In: Paulman, P., Taylor, R. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-1-4939-0779-3_85-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0779-3_85-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-1-4939-0779-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation